hHRS3-CAR-T cells specifically killed CD30+ tumor cells in vitro with efficiency similar to that of murine HRS3-CAR-T, and these T cells significantly inhibited the established CD30+ human lymphoma tumor cells in immunodeficient mice. This evidence concerns the gene TNFRSF8 and neoplasm.